Advances in molecular pathogenesis have elucidated recurrent driver gene mutations, such as KRAS, TP53, and APC, alongside dysregulated signaling pathways including Wnt, RAS-MAPK, and PI3K-AKT, which collectively underpin tumor initiation and progression. Here, KRAS is linked to neoplasm.